PAVmed

Yahoo Finance • last month

Kellanova Becomes Oversold

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a... Full story

Yahoo Finance • last month

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

Newly-formed PAVmed subsidiary to license endoscopic imaging technology designed to identify and facilitate ablative treatment of esophageal dysplasia Lucid Diagnostics to collaborate with PAVmed as a strategic and equity partner on the t... Full story

Yahoo Finance • 2 months ago

PAVmed Q2 2025 slides reveal dramatic cost reduction amid Lucid Diagnostics growth

Introduction & Market Context PAVmed Inc. (NASDAQ:PAVM) presented its Q2 2025 business update on August 14, highlighting significant cost reduction measures and progress across its subsidiaries. The medical technology company, currently t... Full story

Yahoo Finance • 2 months ago

PAVmed Q2 2025 Earnings Preview

* PAVmed (NASDAQ:PAVM [https://seekingalpha.com/symbol/PAVM]) is scheduled to announce Q2 earnings results on Thursday, August 14th, before market open. * The consensus EPS Estimate is -$0.25 [https://seekingalpha.com/symbol/PAVM/earni... Full story

Yahoo Finance • 2 months ago

PAVmed granted 180-day extension to meet Nasdaq minimum bid price

NEW YORK - PAVmed Inc. (NASDAQ:PAVM), a commercial-stage medical technology company with a market capitalization of $10.17 million, announced Wednesday it has received a 180-day extension from Nasdaq to regain compliance with the $1.00 min... Full story

Yahoo Finance • 3 months ago

Lucid says meeting scheduled to determine Medicare coverage for cancer test

[Immunotherapy: A New Frontier in Cancer Detection and Treatment] bymuratdeniz Cancer test maker Lucid Diagnostics (NASDAQ:LUCD [https://seekingalpha.com/symbol/LUCD]), majority owned by PavMed (NASDAQ:PAVM [https://seekingalpha.com/symbo... Full story

Yahoo Finance • 2 years ago

PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK, June 28, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, tod... Full story

Yahoo Finance • 3 years ago

Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results

Conference call to be held today at 4:30 PM EDT NEW YORK, May 11, 2022--(BUSINESS WIRE)--Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid", the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned... Full story